Munk Dialogue with Paul Offit
Munk Dialogue with Paul Offit
The Bivalent COVID-19 Booster: do the benefits outweigh the risks?
Health Canada, the FDA, and the CDC have approved COVID bivalent vaccines to anyone over the age of 12. This booster is different from previous COVID shots, targeting multiple strains of the novel coronavirus, including Omicron sub variants. And while the vaccine is being widely distributed, some epidemiologists are sounding the alarm.
Dr. Paul Offit, Director of the Vaccine Education Center and attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, is one of two members on the FDA committee who voted against advising all adults over the age of 12 to get the jab. Offit joins Rudyard Griffiths for a talk about the Bivalent COVID-19 boosters, who should be getting them, and where more study is warranted.
“The data that we were shown didn’t make it clear that the bivalent vaccine was any better…boosters are a value, but I don’t see why the bivalent one is better than what we have already been getting.”
– PAUL OFFIT
You may also like
February 12, 2025
– Listen
Munk Debate Podcast: Gaza, tariffs, and a constitutional showdown
February 28, 2025
– Listen
Munk Debates Podcast: Stephen Walt and Evelyn Farkas on Trump’s plan for Ukraine and the changing world order
March 7, 2025
– Listen
Munk Debates Podcast: Trump’s trade wars with Jared Bernstein and Oren Cass
March 18, 2025
– Listen
Munk Debates Podcast: Mahmoud Khalil, Democrats in disarray, and can tariffs actually benefit the working class?
April 3, 2025
– Listen
Munk Debates Podcast: Tension with Iran, Greenland annexation, and Chinese aggression against Taiwan
May 29, 2024
– Watch
Munk Debate on Trump’s America
April 16, 2025
– Listen
Munk Dialogue with Andrew Coyne: how the Liberals are benefiting from the Canada-US trade war
April 22, 2025
– Listen
Munk Dialogue with Andrew Coyne: The Conservative Party’s failure to provide a roadmap for change
April 30, 2025
